Skip to main content
Median Technologies logo

Median Technologies — Investor Relations & Filings

Ticker · ALMDT ISIN · FR0011049824 LEI · 9695007YG6O07A8N6395 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 797 across all filing types
Latest filing 2026-01-05 Declaration of Voting R…
Country FR France
Listing PA ALMDT

About Median Technologies

https://mediantechnologies.com/

Median Technologies develops and provides innovative imaging solutions and services focused on oncology. The company utilizes proprietary artificial intelligence, computer vision, and signal processing technologies to transform medical images into actionable clinical insights. These insights aid healthcare professionals in the diagnosis, treatment, and monitoring of cancer. Median Technologies serves two primary markets: biopharmaceutical companies, by providing imaging services for oncology clinical trials, and healthcare providers, by offering software for clinical practice, including cancer screening. Its portfolio includes the eyonis® platform, designed for the early detection of cancer.

Recent filings

Filing Released Lang Actions
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a regulatory disclosure titled 'Disclosure of total number of voting rights and number of shares in the capital'. It cites specific French regulatory articles (L-223-8 II of the Code de Commerce and 223-16 of the AMF General Regulations) regarding share capital and voting rights. This type of periodic disclosure of share capital and voting rights does not fit into the specific categories of 'Major Shareholding Notification' (which tracks individual investors) or 'Share Issue/Capital Change' (which tracks specific corporate actions). It is a standard regulatory filing required by the AMF for listed companies to report their capital structure, making 'RNS' (Regulatory Filings) the most appropriate classification.
2026-01-05 English
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release issued by Median Technologies announcing a new commercial distribution partnership for their product 'eyonis LCS'. It details the nature of the agreement, the strategic rationale, and the regulatory status of the product. As this is a general corporate announcement regarding a business partnership that does not fit into specific categories like M&A (which typically involves ownership changes or takeovers) or financial reporting, it is classified as a general regulatory filing/announcement.
2025-12-08 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Median Technologies announcing a strategic commercial distribution agreement for their medical software, eyonis® LCS. It details the nature of the partnership, the regulatory status of the product (FDA 510(k) review), and the expected commercial impact. As this is a corporate announcement regarding business operations and strategic partnerships that does not fit into specific financial reporting categories like 10-K or IR, it falls under the general regulatory filing/announcement category.
2025-12-08 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a regulatory disclosure titled 'Déclaration du nombre total de droits de vote et du nombre d'actions composant le capital', which is a standard monthly requirement under French financial regulations (AMF). It provides the total number of shares and voting rights as of a specific date. This type of filing is specifically categorized as a regulatory announcement regarding share capital and voting rights, which falls under the 'RNS' (Regulatory Filings) category as it does not represent a change in share capital (SHA) or a transaction in own shares (POS), but rather a periodic disclosure of the current state of capital structure.
2025-12-03 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal disclosure of the total number of voting rights and shares in the capital, issued pursuant to French regulatory requirements (Article L-223-8 II of the Code de Commerce and AMF General Regulations). This type of disclosure is a standard regulatory requirement for listed companies to report their capital structure and voting rights, which falls under the category of regulatory filings or specific share capital disclosures. Given the options, 'RNS' (Regulatory Filings) is the most appropriate classification for this type of mandatory regulatory disclosure.
2025-12-03 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release from Median Technologies announcing their participation in the RSNA 2025 conference to present their 'eyonis® LCS' software. It provides details on scientific and industrial presentations, the company's clinical trial status, and contact information. It does not constitute a formal financial report (10-K, IR), a shareholder meeting document, or a specific regulatory filing. As it is a general corporate announcement regarding company activities and events, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate announcements.
2025-11-25 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.